These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32968829)

  • 1. Stimuli-Responsive Insulin Delivery Devices.
    Fuchs S; Shariati K; Ma M
    Pharm Res; 2020 Sep; 37(10):202. PubMed ID: 32968829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.
    Wang J; Wang Z; Yu J; Kahkoska AR; Buse JB; Gu Z
    Adv Mater; 2020 Apr; 32(13):e1902004. PubMed ID: 31423670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
    Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Therapy and Diabetic Pregnancy.
    Napoli A
    Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed-loop insulin delivery: current status of diabetes technologies and future prospects.
    Majeed W; Thabit H
    Expert Rev Med Devices; 2018 Aug; 15(8):579-590. PubMed ID: 30027775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes.
    Dovc K; Battelino T
    Expert Opin Drug Deliv; 2020 Feb; 17(2):157-166. PubMed ID: 32077342
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of implantable biosensors for closed-loop glucose control and other drug delivery applications.
    Scholten K; Meng E
    Int J Pharm; 2018 Jun; 544(2):319-334. PubMed ID: 29458204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Care for Insulin-Requiring Patients Without Closed Loop.
    Lal RA; Buckingham B; Maahs DM
    Diabetes Technol Ther; 2018 Jun; 20(S2):S285-S291. PubMed ID: 29916743
    [No Abstract]   [Full Text] [Related]  

  • 11. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 13. Latest advances in glucose-responsive microneedle-based systems for transdermal insulin delivery.
    Martínez-Navarrete M; Pérez-López A; Guillot AJ; Cordeiro AS; Melero A; Aparicio-Blanco J
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130301. PubMed ID: 38382776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review.
    Siegel RA
    J Control Release; 2014 Sep; 190():337-51. PubMed ID: 24984012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Closed-Loop Control Validation Studies for Optimal Insulin Delivery in Type 1 Diabetes.
    Zavitsanou S; Mantalaris A; Georgiadis MC; Pistikopoulos EN
    IEEE Trans Biomed Eng; 2015 Oct; 62(10):2369-78. PubMed ID: 25935026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications.
    Pandey M; Choudhury H; Yi CX; Mun CW; Phing GK; Rou GX; Singh BJKAAJ; Jhee ANA; Chin LK; Kesharwani P; Gorain B; Hussain Z
    Curr Drug Targets; 2018; 19(15):1782-1800. PubMed ID: 29792143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.